STORM-PE: Mechanical Thrombectomy Boosts Walking and Daily Living Gains

Why It Matters

Improved walking capacity and near‑normal functional status translate into faster return to daily life, strengthening the case for endovascular therapy as a standard adjunct to anticoagulation in intermediate‑high‑risk PE patients.

Key Takeaways

• Mechanical thrombectomy improved 90‑day 6‑minute walk distance to 479 m vs 368 m
• 97% of thrombectomy patients reached NYHA class I versus 76% with anticoagulation
• Endovascular therapy showed higher rates of returning to pre‑PE functional status
• Combined data from STORM‑PE and HI‑PEITHO may prompt guideline updates
• Experts call this the “golden age” of pulmonary embolism care

Pulse Analysis

The STORM‑PE trial’s latest interim results provide concrete functional evidence that mechanical thrombectomy can accelerate recovery after acute intermediate‑high‑risk pulmonary embolism. Patients treated with computer‑assisted vacuum thrombectomy (CAVT) not only walked nearly 100 meters farther in the six‑minute walk test at 90 days, but also overwhelmingly returned to NYHA class I, indicating near‑normal right‑heart performance. These outcomes go beyond surrogate imaging metrics, directly addressing the quality‑of‑life concerns that drive patient and provider decision‑making.

These findings arrive at a pivotal moment for PE management. Earlier studies, such as the HI‑PEITHO trial, demonstrated short‑term mortality and hemodynamic benefits of catheter‑directed therapies, while STORM‑PE adds robust functional data. Together they challenge the current AHA/ACC guideline classifications, which still assign only a class 2a/2b recommendation for endovascular interventions. The growing body of level I evidence is prompting specialty societies to consider more definitive guidance, potentially moving mechanical thrombectomy into a first‑line role for appropriately selected patients.

For clinicians, the practical implication is clear: offering thrombectomy can shorten the road to baseline activity, reduce dyspnea, and improve overall patient satisfaction. Hospitals that develop Pulmonary Embolism Response Teams (PERT) are likely to see increased adoption of CAVT as the procedural safety profile becomes better understood. As the field moves toward a "golden age" of PE care, the focus shifts from merely surviving the event to restoring full functional capacity, a metric that resonates with patients, payers, and providers alike.